Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1991
05/07/1991CA2029338A1 Acat inhibitors
05/07/1991CA1283859C Penicillamine for treating immune damaging illnesses
05/04/1991CA2029268A1 Peptides aiding nerve regeneration
05/03/1991CA2029216A1 Process of producing modified superoxide dismutase
05/02/1991WO1991005871A1 Bispecific heteroantibodies with dual effector functions
05/02/1991WO1991005802A1 Osteogenic devices
05/02/1991WO1991005798A1 Compositions and methods for treating or preventing infections in canine and feline animals
05/02/1991WO1991005537A1 Method of accelerating wound and ulcer healing and treating periodontal disease
05/02/1991EP0425211A1 Substituted 5-((tetrazolyl)alkenyl)-imidazoles
05/02/1991EP0425096A1 Polypeptides useful as blockers of calcium channels
05/02/1991EP0424990A1 The manufacture and expression of large structural genes
05/02/1991EP0424954A1 Pharmaceutical composition for treatment of osteoporosis
05/02/1991EP0424722A2 Substituted (quinolin-2-yl-methoxy)phenyl-thioureas
05/02/1991DE3936328A1 Pharmazeutische praeparate Pharmaceutical products
05/02/1991CA2042577A1 Osteogenic devices
05/02/1991CA2027935A1 Imidazo [4,5-b] quinolinyloxyalkanoic acid amides with enhanced water solubility
05/01/1991WO1991006573A1 Inhibitor of laminin neurite promoting activity
05/01/1991CA2066658A1 Inhibitor of laminin neurite promoting activity
05/01/1991CA2028880A1 Condensed imidazole derivatives and processes for preparation thereof
05/01/1991CA2026686A1 Method for preventing onset of type ii diabetes employing an ace inhibitor
04/1991
04/30/1991US5011859 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
04/30/1991US5011838 Antiallergens, antihistamines
04/28/1991WO1991006564A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE
04/28/1991WO1991006539A1 2-anilino phenylacetic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991WO1991006538A1 Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991WO1991006537A2 Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991CA2070422A1 Substituted indole-, indene-, pyranoindole and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991CA2067138A1 Substituted benzoylbenzene-, biphenyl-and 2-oxazole-alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991CA2067135A1 2-anilino phenylacetic acid derivatives as inhibitors of pla2 and lipoxygenase
04/26/1991CA2028314A1 Substituted (quinolin-2-yl-methoxy)phenyl-carbonylureas
04/26/1991CA2027937A1 Substituted 5-¬ (tetrazolyl)alkenyl|imidazoles
04/25/1991WO1991006647A1 Gastrin releasing peptide receptor
04/25/1991WO1991006646A1 Solubilization and purification of the gastrin releasing peptide receptor
04/25/1991WO1991006296A1 Bafilomycine macrolides for treatment of bone affecting diseases
04/25/1991CA2071914A1 Bafilomycine macrolides for treatment of bone affecting diseases
04/25/1991CA2069965A1 Solubilization and purification of the gastrin releasing peptide receptor
04/25/1991CA2067766A1 Gastrin releasing peptide receptor
04/24/1991WO1991005556A1 Camptothecin analogs as potent inhibitors of human colorectal cancer
04/24/1991EP0424350A1 Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol
04/24/1991EP0424317A2 Pyrimidines
04/24/1991EP0424311A1 Paramagnetic oil emulsion as MRI contrast agents
04/24/1991EP0423943A2 Use of collagenase inhibitors in the treatment of demyelinating diseases, in particular multiple sclerosis
04/24/1991EP0423845A1 A synthetic gene encoding gamma-interferon
04/24/1991EP0423697A2 Emulsion of lipid containing a prostaglandin analogue
04/24/1991EP0423419A1 Inhibitive agent against activity of alpha-amylase
04/24/1991EP0423326A1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
04/24/1991EP0423207A1 A migration stimulating factor
04/24/1991CN1050875A Aroyl-urres
04/24/1991CA2067491A1 Camptothecin analogs as potent inhibitors of human colorectal cancer
04/24/1991CA2026642A1 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
04/24/1991CA2026602A1 Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
04/23/1991US5010204 Glaucoma treatment
04/23/1991US5010097 Collagenase inhibitors, antiarthritic agents
04/23/1991US5010095 N-(W-substituted alkyl)-'-(imidazol-4-yl)alkyl)guanidine
04/23/1991US5010080 !anticarcinogenic agents
04/23/1991US5010079 Indolone derivatives, their preparation and their application in therapy
04/23/1991US5010073 Use of liposomes as carriers for metalloporphyrins
04/23/1991US5010072 Lactamimides as calcium antagonists
04/23/1991US5010065 Cyclodextrin clathrates of 5-cyanoprostacyclin derivatives and their use as pharmaceutical agents
04/23/1991US5009891 Brewing extract plant seeds, vegetable grains and germs or rice bran; oil
04/23/1991CA1283500C Thiopeptolide substrates for vertebrate collagenase
04/23/1991CA1283499C Peptides
04/23/1991CA1283422C Hydroxyvitamin d _compounds and process for preparing same
04/23/1991CA1283419C Substituted di-t-butylphenols
04/23/1991CA1283361C Antiviral combinations
04/22/1991CA2028042A1 Substituted (quinolin-2-yl-methoxy)phenylthioureas
04/21/1991WO1991005543A1 Pharmaceutical and cosmetic depigmentation compositions with a caffeic acid base
04/20/1991CA2027839A1 Pyrimidines
04/20/1991CA2026545A1 Paramagnetic oil emulsiions as mri contrast agents
04/19/1991WO1991005565A1 BIOSYNTHETIC CONSTRUCTS OF TGF-$g(b)
04/19/1991CA2070393A1 Biosynthetic constructs of tgf-beta
04/18/1991WO1991005552A1 Method and compositions for inhibition of disorders associated with oxidative damage
04/18/1991WO1991004977A1 Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
04/18/1991WO1991004748A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX
04/18/1991WO1991004673A1 Feed additive for poultry, poultry feed and method of poultry feeding
04/18/1991WO1991004664A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems
04/18/1991CA2067803A1 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
04/18/1991CA2066046A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems
04/17/1991EP0423015A1 Effervescent nails composition
04/17/1991EP0422878A1 (2-Imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
04/17/1991EP0422846A2 Aroyl-ureas
04/17/1991EP0422697A1 A consensus leukocyte interferon and a gene encoding it
04/17/1991EP0422566A1 A process for the preparation of 3-(L-pyroglutamyl)-L-thiazolidine-4-carboxylic acid derivatives
04/17/1991EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m
04/17/1991EP0422104A1 Angiogenic potentiating peptides which potentiate angiogenic factors
04/17/1991EP0422079A1 Tricyclic lipoxygenase inhibiting compounds, compositions, methods of use
04/16/1991US5008374 IL-1α derivatives and drugs
04/16/1991US5008292 Pesticidal method
04/16/1991US5008283 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
04/16/1991US5008273 Amino acid derivatives and their pharmaceutical use
04/16/1991US5008272 Antagonists; useful in treatment of psychotic disorders, central nervous system disorder; antidepressant
04/16/1991US5008268 2-aminopyrimidinone derivatives
04/16/1991US5008266 4(3H)-quinazolinone derivatives and pharmaceutical compositions
04/16/1991US5008119 Increasing metallothioneim level in host
04/16/1991CA1283119C Hydroxyacetic acid derivatives for the treatment of diabetic complications
04/15/1991WO1991005783A1 Heterocyclic compounds
04/14/1991WO1991005797A1 Methods and compositions for healing bone
04/14/1991WO1991005754A2 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same
04/14/1991CA2067505A1 Methods and compositions for healing bone
04/14/1991CA2044162A1 Long-chained fatty alcohol derivatives, their applications, specifically as cytotrphic and cytoprotecting molecules, and pharmaceutical compounds containing same